miR‐33 in cardiometabolic diseases: lessons learned from novel animal models and approaches
Abstract miRNAs have emerged as critical regulators of nearly all biologic processes and important therapeutic targets for numerous diseases. However, despite the tremendous progress that has been made in this field, many misconceptions remain among much of the broader scientific community about the...
Saved in:
| Main Authors: | Nathan L Price, Leigh Goedeke, Yajaira Suárez, Carlos Fernández‐Hernando |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2021-05-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.202012606 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Macrophage deficiency of miR‐21 promotes apoptosis, plaque necrosis, and vascular inflammation during atherogenesis
by: Alberto Canfrán‐Duque, et al.
Published: (2017-07-01) -
Chronic miR‐29 antagonism promotes favorable plaque remodeling in atherosclerotic mice
by: Victoria Ulrich, et al.
Published: (2016-05-01) -
The impact of hsa-miR-1972 on the expression of von Willebrand factor in breast cancer progression regulation
by: Changjiang Yu, et al.
Published: (2024-11-01) -
MiRNA-mRNA network in osteoporotic fractures proposes the functional mechanism of hsa-miR-32-3p/TNFSF11 axis
by: Yukai Zeng, et al.
Published: (2025-04-01) -
Circ-PRMT5 promotes gastric cancer progression by sponging miR-145 and miR-1304 to upregulate MYC
by: Wenbo Du, et al.
Published: (2019-12-01)